Targeting of lysosomal-bound protein mEAK-7 for cancer therapy
mEAK-7 (mammalian EAK-7 or MTOR-associated protein, eak-7 homolog), is an evolutionarily conserved lysosomal membrane protein that is highly expressed in several cancer cells. Multiple recent studies have identified mEAK-7 as a positive activator of mTOR (mammalian/mechanistic target of rapamycin) s...
Main Authors: | Insoon Chang, Yi-Ling Loo, Jay Patel, Joe Truong Nguyen, Jin Koo Kim, Paul H. Krebsbach |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1375498/full |
Similar Items
-
Autophagy and the Lysosomal System in Cancer
by: Suresh Kumar, et al.
Published: (2021-10-01) -
Lysosomal Exocytosis: The Extracellular Role of an Intracellular Organelle
by: Brunella Tancini, et al.
Published: (2020-12-01) -
<i>GLA</i> Mutations Suppress Autophagy and Stimulate Lysosome Generation in Fabry Disease
by: Ping Li, et al.
Published: (2024-03-01) -
Quercetin ameliorates autophagy in alcohol liver disease associated with lysosome through mTOR-TFEB pathway
by: Yanyan Li, et al.
Published: (2019-01-01) -
mEAK-7 Forms an Alternative mTOR Complex with DNA-PKcs in Human Cancer
by: Joe Truong Nguyen, et al.
Published: (2019-07-01)